Search - Université Paris Cité Access content directly

Filter your results

20 Results
authFullName_s : Pascal Artru
Image document

Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study

Marie Auvray Kuentz , Vincent Hautefeuille , Louis de Mestier , Clelia Coutzac , Thierry Lecomte et al.
International Journal of Cancer, 2023, ⟨10.1002/ijc.34414⟩
Journal articles hal-03969427v1

Prognosis and chemosensitivity of non-V600E BRAF mutations in metastatic colorectal carcinoma (mCRC): An AGEO French multicenter retrospective cohort.

Aline Derosiere , Vincent Nicolai , David Malka , Astrid Pozet , Julien Lazartigues et al.
Journal of Clinical Oncology, 2019, 37 (15, S), ⟨10.1200/JCO.2019.37.15\_suppl.3575⟩
Journal articles hal-03606012v1

FLASH-RAS : Etat des lieux des tests RAS chez des patients atteint d’un cancer colorectal métastatique en 2014

Jean-Louis Merlin , Astrid Lièvre , Pierre Laurent-Puig , Michel Ducreux , Pascal Artru et al.
7ème colloque de pharmaco-épidémiologie, Jun 2015, Paris, France
Conference papers hal-01241770v1

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)

Debora Basile , Chloé Broudin , Jean François J.F. Emile , Antoine Falcoz , Franck Pagès et al.
Annals of Oncology, 2022, 33 (6), pp.628-637. ⟨10.1016/j.annonc.2022.03.002⟩
Journal articles hal-03703634v1
Image document

RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014

Astrid Lièvre , Jean-Louis Merlin , Jean-Christophe Sabourin , Pascal Artru , Sabine Tong et al.
Digestive and Liver Disease, 2018, 50 (5), pp.507-512. ⟨10.1016/j.dld.2017.12.029⟩
Journal articles hal-01778377v2

Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study

Sonia Zaibet , Vincent Hautefeuille , Edouard Auclin , Astrid Lièvre , David Tougeron et al.
British Journal of Cancer, 2022, 126 (10), pp.1394-1400. ⟨10.1038/s41416-022-01713-w⟩
Journal articles hal-03555280v1

NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)

Antoine Brouquet , Jean-Baptiste Bachet , Florence Huguet , Mehdi Karoui , Pascal Artru et al.
BMC Cancer, 2020, 20 (1), ⟨10.1186/s12885-020-06968-1⟩
Journal articles hal-03597474v1

Review of the current status of KRAS mutation testing in France in 2011: The Flash-KRAS study

Pascal Artru , Michel Ducreux , Astrid Lièvre , Michel Guiu , Jean-Louis Merlin et al.
Annual Meeting of the American Society of Clinical Oncology, ASCO'2012, Jun 2012, Chicago, Illinois, United States. pp.CDROM
Conference papers hal-00747407v1
Image document

Prognostic factors of colorectal cancer patients with brain metastases

Pauline Roussille , Marie Auvray , Damien Vansteene , Thierry Lecomte , Eugénie Rigault et al.
Radiotherapy & Oncology, 2021, 158, pp.67-73. ⟨10.1016/j.radonc.2021.02.006⟩
Journal articles hal-03237457v1
Image document

Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study

Anne-Laure Pointet , David Tougeron , Simon Pernot , Astrid Pozet , Dominique Béchade et al.
Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.295 - 301. ⟨10.1016/j.clinre.2019.08.009⟩
Journal articles hal-03491049v1

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

Nicolas Williet , Angélique Saint , Anne-Laure Pointet , David Tougeron , Simon Pernot et al.
Therapeutic Advances in Gastroenterology, 2019, 12, pp.175628481987866. ⟨10.1177/1756284819878660⟩
Journal articles hal-02532994v1
Image document

Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study

Claire Gallois , Pascal Artru , Astrid Lièvre , Edouard Auclin , Thierry Lecomte et al.
European Journal of Cancer, 2019, 119, pp.35 - 43. ⟨10.1016/j.ejca.2019.07.011⟩
Journal articles hal-03487266v1
Image document

BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study

Leo Mas , Jean-Baptiste Bachet , Valérie Taly , Olivier Bouché , Julien Taïeb et al.
Cancers, 2019, 11 (7), pp.998. ⟨10.3390/cancers11070998⟩
Journal articles inserm-02299478v1

Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.

Florence Huguet , Thierry André , Pascal Hammel , Pascal Artru , Jacques Balosso et al.
Journal of Clinical Oncology, 2007, 25 (3), pp.326-31. ⟨10.1200/JCO.2006.07.5663⟩
Journal articles inserm-00383864v1

Etat des lieux des tests RAS chez les patients atteints de cancer colorectal métastatique en 2014

Jean-Christophe Sabourin , Jean-Louis Merlin , Astrid Lièvre , Michel Ducreux , Pascal Artru et al.
Carrefour Pathologie, Nov 2015, Paris, France
Conference papers hal-01241777v1

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy , Pascal Hammel , Mohamed Hebbar , Meher Ben Abdelghani , Alice Wei et al.
New England Journal of Medicine, 2018, 379 (25), pp.2395-2406. ⟨10.1056/NEJMoa1809775⟩
Journal articles hal-02281628v1

Etat des lieux du test KRAS chez des patients atteints d'un cancer colorectal métastatique, en France en 2011 - Etude Flash-KRAS

Astrid Lièvre , Pascal Artru , Michel Guiu , Pierre Laurent-Puig , Jean-Louis Merlin et al.
Journées Francophones d'Hépatogastro-entérologie et d'Oncologie Digestive, JFHOD 2012, Mar 2012, Paris, France. pp.CDROM
Conference papers hal-00747738v1

Étude Flash KRAS : étude transversale observationnelle, rétrospective, faisant un état des lieux du test KRAS en 2011 chez des patients ayant commencé récemment un traitement de première ligne pour un cancer colorectal métastatique (CCRm) : méthodologie de l'étude et premiers résultats

Jean-Christophe Sabourin , Pascal Artru , Michel Ducreux , Michel Guiu , Astrid Lièvre et al.
Carrefour Pathologie 2011, Nov 2011, Paris, France. pp.CDROM, ⟨10.1016/j.annpat.2011.09.038⟩
Conference papers hal-00747875v1
Image document

Review of the current status of RAS mutation testing in patients with metastatic colorectal cancer (mCRC): Flash-RAS study

Jean-Christophe Sabourin , Astrid Lièvre , Jean-Louis Merlin , Michel Ducreux , Pascal Artru et al.
18th Annual European Congress of the International Society for Pharmacoeconomics and Outcome Research, ISPOR, Nov 2015, Milan, Italy
Conference poster hal-01241776v1

The KRAS mutation detection within the initial management of patients with metastatic colorectal cancer: a status report in France in 2011

Astrid Lièvre , Pascal Artru , Michel Guiu , Pierre Laurent-Puig , Jean-Louis Merlin et al.
European Journal of Cancer, 2013, 49 (9), pp.2126-2133. ⟨10.1016/j.ejca.2013.02.016⟩
Journal articles hal-00974915v1